Clinical Trials Browser

Breast Neoplasms

Breast Neoplasms

Polycystic Ovary Syndrome

Breast Neoplasms, Breast Neoplasms, Male

Advanced Breast Cancer

Breast Neoplasms

Carcinoma, Intraductal, Noninfiltrating

Breast Neoplasms

Anatomic Stage II Breast Cancer AJCC v8

Breast Neoplasms

Breast Neoplasms

Low Grade Serous Ovarian Cancer

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Breast Neoplasms, Male

HR+/HER2- Breast Cancer

Fallopian Tube Neoplasms, Ovarian Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Carcinoma In Situ

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Breast Neoplasms, Male

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site

Breast Cancer Female

Breast Neoplasms, Neoplasms

Breast Neoplasms, Neoplasms

Infertility, Polycystic Ovary Syndrome

Breast Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Fallopian Tube Neoplasms, Peritoneal Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Breast Neoplasm Female

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer

Breast Neoplasms

Breast Neoplasms

Clinical Trials

OPERA-02

DEBRA

A Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth in Women With PCOS

Adjuvant WIDER

EvoPAR-BR01

TAILORx

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

CAMBRIA-1

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

INAVO123

EMBER-4

RAMP 301

SIE-3

Letrozole After Tamoxifen in Treating Women With Breast Cancer

ELEGANT

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With High-Risk Early Breast Cancer

MNEMOSYNE

OPERA-01

LoTam

FourLight-3

MECCA

POWER II

A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

PATINA

e3

VERITAC-3

MONARCH plus

MONARCH 3

A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer

CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)

SERENA-6

POETIC-A

OVELIA

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

Letrozole Step up Protocol for Ovulation Induction in Infertile Women With Polycystic Ovary Syndrome

PADA-1

A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]

MATAO

AMBRE

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

EMERALD

AMEERA-5

TREAT ctDNA

A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer

Comparing Endocrine Therapy Combined With High-Dose Palbociclib and Hydroxychloroquine to Endocrine Therapy Combined With Standard-Dose Palbociclib for Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer

CAMBRIA-2

Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer